EUVIMEDEUVIMED entdecken
Kohortenstudie

Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501)

Shigeo Matsunaga, Takashi Shuto, Masaaki Yamamoto, Shoji Yomo, Takeshi Kondoh, Tatsuya Kobayashi, Manabu Sato, Hisayo Okamoto, Toru Serizawa, Osamu Nagano, Hiroyuki Kenai, Takuma Obara und 10 weitere

Stereotactic and Functional Neurosurgery · 2018 · 96 (3) · 162-171

DOI: 10.1159/000489948 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Stereotactic and Functional Neurosurgery, online erschienen am 03.07.2018. Verfasst von Shigeo Matsunaga und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Japan. Die Arbeit wurde bisher 24-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidences of metastatic brain tumors from malignant melanomas have increased and survival has been prolonged by novel molecular targeted agents and immunotherapy. However, malignant melanomas are uncommon in Asian populations.

Objectives

We retrospectively analyzed treatment efficacy and identified prognostic factors impacting tumor control and survival in Japanese melanoma patients with brain metastases treated with gamma knife radiosurgery (GKRS).

Methods

We retrospectively reviewed the medical records of 177 patients with 1,500 tumors who underwent GKRS for brain metastases from malignant melanomas. This study was conducted by the Japanese Leksell Gamma Knife Society (JLGK1501).

Results

Six and 12 months after GKRS, the cumulative incidences of local tumor recurrence were 9.2 and 13.8%. Intratumoral hemorrhage (p < 0.0001) and larger tumor volume (p = 0.001) in GKRS were associated with significantly poorer local control outcomes. The use of immune checkpoint inhibitors before GKRS was significantly associated with symptomatic adverse events (p = 0.037). The median overall survival time after the initial GKRS was 7.3 months. Lower Karnofsky performance status scores (p = 0.016), uncontrolled primary cancer (p < 0.0001), and multiple brain metastases (p = 0.014) significantly influenced unfavorable overall survival outcomes. The cumulative incidences of neurological death 6 and 12 months after GKRS were 9.7 and 17.4%, those of neurological deterioration were 14.2 and 19.6%, and those of new tumor appearance were 34.5 and 40.5%.

Conclusions

The results of the present multicenter study suggest that GKRS is a relatively effective and safe modality for control of tumor progression in Japanese patients with brain metastases from malignant melanomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAged, 80 and overBrain NeoplasmsFemaleFollow-Up StudiesHumansIncidenceMaleMelanomaMiddle AgedNeoplasm Recurrence, LocalRadiosurgeryRetrospective StudiesTreatment OutcomeTumor Burden

Stichwörter der Autor:innen

Brain metastasesGamma knifeImmunotherapyMalignant melanomaStereotactic radiosurgery

Autor:innen und Institutionen

  • Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Japan.
  • Stereotactic Radiotherapy Center, Yokohama Rosai Hospital, Yokohama, Japan.
  • Katsuta Hospital Mito Gamma House, Hitachinaka, Japan.
  • Division of Radiation Oncology, Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan.
  • Department of Neurosurgery, Shinsuma Hospital, Kobe, Japan.
  • Nagoya Radiosurgery Center, Nagoya Kyoritsu Hospital, Nagoya, Japan.

Zitieren

APA

Matsunaga, S., Shuto, T., Yamamoto, M., Yomo, S., Kondoh, T., Kobayashi, T., Sato, M., Okamoto, H., Serizawa, T., Nagano, O., Kenai, H., Obara, T., Iwai, Y., Yasuda, S., Hasegawa, T., Kubo, K., Shidoh, S., Mori, K., Hayashi, M., …, & Gondo, M. (2018). Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501). Stereotactic and Functional Neurosurgery, 96(3), 162-171. https://doi.org/10.1159/000489948

Vancouver

Matsunaga S, Shuto T, Yamamoto M, Yomo S, Kondoh T, Kobayashi T, et al. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501). Stereotactic and Functional Neurosurgery. 2018;96(3):162-171. doi:10.1159/000489948

BibTeX
@article{Matsunaga2018,
  author = {Matsunaga, Shigeo and Shuto, Takashi and Yamamoto, Masaaki and Yomo, Shoji and Kondoh, Takeshi and Kobayashi, Tatsuya and Sato, Manabu and Okamoto, Hisayo and Serizawa, Toru and Nagano, Osamu and Kenai, Hiroyuki and Obara, Takuma and Iwai, Yoshiyasu and Yasuda, Soichiro and Hasegawa, Toshinori and Kubo, Kenji and Shidoh, Satoka and Mori, Katsuharu and Hayashi, Motohiro and Inoue, Akira and Onoue, Shinji and Gondo, Masazumi},
  title = {Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501)},
  journal = {Stereotactic and Functional Neurosurgery},
  year = {2018},
  volume = {96},
  number = {3},
  pages = {162--171},
  doi = {10.1159/000489948}
}
Kostenlos starten →